Federal contractor profile

XLCARE PHARMACEUTICALS INC

UEI MEAUS5WHBJJ7CAGE 86SL9Company website ↗

Active

Woman Owned Small BusinessWoman Owned BusinessSmall Business

Overview

Legal name: XLCARE PHARMACEUTICALS INC
Registered location: LAWRENCEVILLE, GA, USA
Website: Company website ↗
Primary NAICS: 325412 — Pharmaceutical Preparation Manufacturing
Latest award activity: Sep 10, 2026

Read company summary

XLCARE PHARMACEUTICALS INC is associated with UEI MEAUS5WHBJJ7 and CAGE 86SL9 in public federal records. AcornBids currently links 19 prime awards totaling $0 in obligations to this entity. Its largest recorded federal customer by obligations is Department of Veterans Affairs. Its recorded federal awards include work classified as Pharmaceutical Preparation Manufacturing. These categories describe the loaded award records, not a complete list of company capabilities. Its primary SAM.gov NAICS is 325412 (Pharmaceutical Preparation Manufacturing). Its public SAM.gov registration lists LAWRENCEVILLE, GA, USA.

At a glance

Lifetime prime obligations$0

Prime awards19

Awards with future end dates0

Top-agency concentration

Not available

Why this customer concentration

Detailed agency totals are not available in this stored profile.

Largest positive coded-agency total ÷ all positive coded-agency totals × 100

Missing data is shown as unavailable.

Prime contract obligations across loaded award records. Obligations are not revenue or contract ceilings. Summary updated Sep 27, 2026. Refresh pending; these totals may be out of date.

Business information

Public SAM.gov registration details.

Legal name: XLCARE PHARMACEUTICALS INC
UEI: MEAUS5WHBJJ7
CAGE: 86SL9
Registered address: 242 S CULVER ST, LAWRENCEVILLE, GA, 30046, USA
Registration status: Active
Primary NAICS: 325412 — Pharmaceutical Preparation Manufacturing
SAM activation: Jun 3, 2026
Initial registration: Sep 5, 2018
Entity start: Nov 22, 2016
SAM updated: Jun 3, 2026
Registration expires: Jun 3, 2027
Fiscal year end: Apr 30
Place of incorporation: NY, USA

View SAM.gov source

Federal award analysis

Net transaction obligations by federal fiscal period.

Transaction history is not available in the loaded data. Annual funding is not estimated from current award totals.

Recent federal awards

Prime contract awards. Select an award to review its history and source evidence.

Award / description	Awarding agency	Obligations	Start date	End date
36E79726D00073 LINE ITEMS FOR MONTELUKAST 10MG TABLET. AWARDED FOR A BASE YEAR OF 5/10/2026 TO 5/9/2027 PLUS 4 ONE-YEAR OPTION PERIODS.	Department of Veterans Affairs	$24.8M	May 10, 2026	Not available
36E79724D0034NEW AWARD FOR OXCARBAZEPINE WITH XLCARE PHARMACEUTICALS. PERIOD OF PERFORMANCE IS OCT 14, 2024 TO OCT 13, 2025 WITH FOUR ONE-YEAR OPTIONS	Department of Veterans Affairs	$11.1M	Oct 14, 2024	Not available
36F79726D012065 I B, DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS, FSS CONTRACT AWARD	Department of Veterans Affairs	$50.0M	Jun 1, 2026	Not available
36E79725D0037NEW AWARD FOR LOSARTAN TABLETS WITH XLCARE PHARMACEUTICALS, INC. PERIOD OF PERFORMANCE IS 9/24/2025-9/23/2026.	Department of Veterans Affairs	$37.9M	Sep 24, 2025	Not available
36E79723D0027NEW AWARD FOR GABAPENTIN CAPSULES WITH XLCARE PHARMACEUTICALS, INC. PERIOD OF PERFORMANCE IS NOVEMBER 11, 2023 THROUGH NOVEMBER 10, 2024 WITH FOUR ONE YEAR OPTIONS.	Department of Veterans Affairs	$54.1M	Nov 11, 2023	Not available
36E79725D0004NEW AWARD FOR LEVOTHYROXINE NA TABLETS WITH XLCARE PHARMACEUTICALS, INC. BASE YEAR ORDERING PERIOD IS JAN 27, 2025 THROUGH JAN 26, 2026 WITH FOUR ONE-YEAR OPTIONS	Department of Veterans Affairs	$40.1M	Jan 27, 2025	Not available
36E79725D0045NEW AWARD FOR TOPIRAMATE TABLETS WITH XLCARE. ORDERING PERIOD IS OCT 31, 2025 TO OCT 30, 2026 WITH FOUR ONE-YEAR OPTIONS.	Department of Veterans Affairs	$14.1M	Oct 31, 2025	Not available
36E79726D0019NEW AWARD FOR LEVETIRACETAM TABLETS WITH XLCARE PHARMACEUTICALS. ORDERING PERIOD FEB 5, 2026 TO MAY 23, 2026, WITH FOUR ONE-YEAR OPTIONS.	Department of Veterans Affairs	$9.6M	May 24, 2026	Not available
36E79726D0027NEW AWARD FOR CARBIDOPA/LEVODOPA IMMEDIATE-RELEASE (IR) TABLETS WITH XLCARE PHARMACEUTICALS, INC. ORDERING PERIOD IS JUNE 21, 2026 TO JUNE 20, 2027 WITH FOUR ONE-YEAR OPTIONS.	Department of Veterans Affairs	$11.8M	Jun 21, 2026	Not available
36E79724D0018AWARD TO XLCARE PHARMACEUTICALS FOR METHOCARBAMOL TABLETS FOR THE BASE YEAR WITH FOUR ONE-YEAR OPTIONS.	Department of Veterans Affairs	$11.6M	Mar 23, 2024	Not available

Explore, filter and export all awards →Subcontracts Grants & subgrants

Registration, certifications & contacts

Registration evidence	Date
SAM updated	Jun 3, 2026
Source loaded	Oct 17, 2026
Initial registration	Sep 5, 2018
Entity start	Nov 22, 2016

Registration classifications: Self Certified Small Disadvantaged Business, Woman Owned Small Business, Woman Owned Business, Small Business. These are separate from the reported certificates above.

Industry	Reported size status
325412 — Pharmaceutical Preparation Manufacturing	Not reported
424210 — Drugs and Druggists' Sundries Merchant Wholesalers	Not reported

Contact	Role	Published contact methods	Evidence	Source date
DENNIS HICKS	Government business	Contact method not published	SAM registration	Not available
DENNIS HICKS	Electronic business	Contact method not published	SAM registration	Not available

Registered industries

325412 — Pharmaceutical Preparation Manufacturing
424210 — Drugs and Druggists' Sundries Merchant Wholesalers

Registered products and services

6505 — Drugs and Biologicals

Registration classifications and published certificates do not by themselves establish eligibility for a particular solicitation. View SAM source